#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	260	CRP	633	633	99.53	CRP.l6.c30.ctg.1	1202	10.8	0	.	p	.	0	K29T	NONSYN	85	87	AAG	390	392	ACG	5;4;4	A;C;G	5;4;4	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	140	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.2	162	10.3	0	.	n	.	0	T879G	SNP	879	879	T	21	21	G	2	G	1	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	140	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.2	162	10.3	0	.	n	.	0	G880A	SNP	880	880	G	22	22	A	2	A	1	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	140	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.2	162	10.3	0	.	n	.	0	A888G	SNP	888	888	A	30	30	G	3	G	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	140	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.2	162	10.3	0	.	n	.	0	C897G	SNP	897	897	C	39	39	G	6	G	5	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	140	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.2	162	10.3	0	.	n	.	0	T898C	SNP	898	898	T	40	40	C	6	C	5	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	140	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.2	162	10.3	0	.	n	.	0	G906T	SNP	906	906	G	48	48	T	11	T	11	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	140	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.2	162	10.3	0	.	n	.	0	G908A	SNP	908	908	G	50	50	A	11	A	11	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	140	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.2	162	10.3	0	.	n	.	0	A918T	SNP	918	918	A	60	60	T	10	T	10	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	140	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.2	162	10.3	0	.	n	.	0	A943G	SNP	943	943	A	85	85	G	22	G,A	21,1	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	140	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.2	162	10.3	0	.	n	.	0	G991T	SNP	991	991	G	133	133	T	14	T	14	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1060	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1496	33.8	0	.	p	.	0	G409S	NONSYN	1225	1227	GGC	1300	1302	AGC	12;12;12	A,G;G;C	7,5;12;12	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1060	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1496	33.8	1	SNP	p	R234F	1	.	.	700	702	TTC	775	777	TTC	54;53;52	T;T;C	54;50;51	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1060	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1496	33.8	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1075	1077	CGT	40;38;38	C;G;T	40;38;38	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1060	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1496	33.8	0	HET	.	.	.	C996A	.	996	996	C	1071	1071	C	41	C,A	26,15	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1060	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1496	33.8	0	HET	.	.	.	T999C	.	999	999	T	1074	1074	T	40	T,C	25,15	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1060	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1496	33.8	0	HET	.	.	.	T180C	.	180	180	T	255	255	T	31	T,C	19,10	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1060	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1496	33.8	0	HET	.	.	.	C261T	.	261	261	C	336	336	C	34	C,T	20,13	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	498	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l6.c4.ctg.1	1738	14.2	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1514	1516	AAA	5;5;5	A;A;A	5;5;5	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	522	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1676	15.6	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1238	1240	GAA	22;21;21	G;A;A	22;21;21	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	132	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	660	9.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	72	G,A	71,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	67	C	67	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	65	C	65	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	50	T	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	60	C	60	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	50	C	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	54	A	54	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	53	A	53	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	52	A	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	53	T	53	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	52	C	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	54	C	54	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	53	A	53	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	48	G	48	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	48	C	48	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	51	T	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	63	G	63	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	72	G	72	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	72	T	72	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	65	T	65	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	61	G,T	60,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	49	C	48	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	45	A	44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	33	C	33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	28	C	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	3	A	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	3	A	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	3	G	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	10	C	10	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	30	T	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	31	G	31	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	33	T	33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	701	46.8	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	57	C	57	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	139	90.65	Pasteurella_multocida_16S.l15.c30.ctg.3	139	8.5	0	.	n	.	0	C990G	SNP	990	990	C	36	36	G	4	G	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	139	90.65	Pasteurella_multocida_16S.l15.c30.ctg.3	139	8.5	0	.	n	.	0	T1002A	SNP	1002	1002	T	48	48	A	5	A	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	139	90.65	Pasteurella_multocida_16S.l15.c30.ctg.3	139	8.5	0	.	n	.	0	A1004G	SNP	1004	1004	A	50	50	G	5	G	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	139	90.65	Pasteurella_multocida_16S.l15.c30.ctg.3	139	8.5	0	.	n	.	0	C1011T	SNP	1011	1011	C	57	57	T	5	T	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	139	90.65	Pasteurella_multocida_16S.l15.c30.ctg.3	139	8.5	0	.	n	.	0	C1023A	SNP	1023	1023	C	69	69	A	8	A	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	139	90.65	Pasteurella_multocida_16S.l15.c30.ctg.3	139	8.5	0	.	n	.	0	T1024A	SNP	1024	1024	T	70	70	A	9	A	9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	139	90.65	Pasteurella_multocida_16S.l15.c30.ctg.3	139	8.5	0	.	n	.	0	T1041G	SNP	1041	1041	T	87	87	G	19	G	19	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1384	Pasteurella_multocida_16S	1551	139	90.65	Pasteurella_multocida_16S.l15.c30.ctg.3	139	8.5	0	.	n	.	0	A1042T	SNP	1042	1042	A	88	88	T	19	T	19	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	531	400	PmrB_1	1092	1076	99.16	PmrB_1.l6.c4.ctg.1	1268	15.3	0	.	p	.	0	H2R	NONSYN	4	6	CAT	196	198	CGT	17;17;17	C;G;T	17;17;17	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	531	400	PmrB_1	1092	1076	99.16	PmrB_1.l6.c4.ctg.1	1268	15.3	0	.	p	.	0	V30I	NONSYN	88	90	GTC	280	282	ATC	21;22;21	A;T;C	21;22;21	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	531	400	PmrB_1	1092	1076	99.16	PmrB_1.l6.c4.ctg.1	1268	15.3	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1039	1041	GGC	17;17;17	G;G;C	17;17;17	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	550	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	1890	14.3	0	.	p	.	0	R8S	NONSYN	22	24	AGA	145	147	AGC	7;7;7	A;G;C	6;7;7	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	550	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	1890	14.3	0	.	p	.	0	I142L	NONSYN	424	426	ATA	547	549	CTA	13;12;12	C;T;A	13;11;11	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	550	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	1890	14.3	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1066	1068	CAA	18;19;18	C;A;A	17;18;18	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	550	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	1890	14.3	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1165	1167	GGT	17;16;16	G;G;T	17;16;16	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	550	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	1890	14.3	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1735	1737	GTT	7;7;6	G;T;T	7;7;6	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	268	PmrE	1167	560	98.04	PmrE.l15.c4.ctg.1	812	8.5	0	.	p	.	0	A125E	NONSYN	373	375	GCA	616	618	GAA	7;7;7	G;A;A	7;7;7	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	268	PmrE	1167	560	98.04	PmrE.l15.c4.ctg.1	812	8.5	0	.	p	.	0	M185T	NONSYN	553	555	ATG	796	798	ACC	1;1;1	A;C;C	1;1;1	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	268	PmrE	1167	626	95.53	PmrE.l15.c4.ctg.2	692	9.5	0	.	p	.	0	M185T	NONSYN	553	555	ATG	12	14	ACC	1;1;1	A;C;C	0;0;0	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	268	PmrE	1167	626	95.53	PmrE.l15.c4.ctg.2	692	9.5	0	.	p	.	0	S225T	NONSYN	673	675	TCC	132	134	ACT	7;6;5	A;C;T	7;6;5	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	268	PmrE	1167	626	95.53	PmrE.l15.c4.ctg.2	692	9.5	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	522	524	ATC	5;5;5	A;T;C	5;5;5	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	368	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1351	13.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	348	aad-	789	789	100.0	aad-.l15.c30.ctg.1	886	17.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1060	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3390	15.3	0	.	p	.	0	T85I	NONSYN	253	255	ACC	460	462	ATC	11;11;11	A;T;C	11;11;11	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1060	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3390	15.3	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2173	2175	AAG	10;10;12	A;A;G	10;10;12	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	460	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1464	15.6	0	.	p	.	0	A22V	NONSYN	64	66	GCC	167	169	GTC	9;9;9	G;T;C	9;9;9	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	460	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1464	15.6	0	.	p	.	0	S269C	NONSYN	805	807	AGC	908	910	TGC	17;17;16	T;G;C	17;17;16	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	960	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	2808	16.8	0	.	p	.	0	S46trunc	TRUNC	136	136	T	157	157	T	14	T	14	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	960	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	2808	16.8	0	.	p	.	0	G148D	NONSYN	442	444	GGC	463	465	GAC	13;13;12	G;A;C	13;13;12	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	960	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	2808	16.8	0	.	p	.	0	F240L	NONSYN	718	720	TTT	739	741	TTA	7;9;9	T;T;A	7;9;9	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	960	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	2808	16.8	0	.	p	.	0	D301N	NONSYN	901	903	GAT	922	924	AAT	15;16;18	A;A;T	15;16;18	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	960	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	2808	16.8	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1709	1709	T	17	T	17	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	182	acrR_2	648	648	99.54	acrR_2.l6.c4.ctg.1	1050	8.7	1	SNP	p	R45C	0	.	.	133	135	CGC	332	334	CGC	11;11;11	C;G;C	11;11;11	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	196	acrS	663	663	98.64	acrS.l6.c4.ctg.1	993	9.7	0	.	p	.	0	L34F	NONSYN	100	102	CTC	286	288	TTC	9;9;9	T;T;C	9;9;9	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	196	acrS	663	663	98.64	acrS.l6.c4.ctg.1	993	9.7	0	.	p	.	0	E122G	NONSYN	364	366	GAG	550	552	GGG	10;10;10	G;G;G	10;10;10	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	268	adiY	762	762	99.61	adiY.l6.c30.ctg.1	1103	12.0	0	.	p	.	0	V136L	NONSYN	406	408	GTT	599	601	CTT	14;14;14	C;T;T	14;14;14	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1094	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3058	18.4	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2101	2103	GCA	19;19;19	G;C;A	19;19;19	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1094	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3058	18.4	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2362	2364	ACC	26;26;26	A;C;C	26;26;26	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1094	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3058	18.4	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2671	2673	GCC	13;13;13	G;C;C	13;13;13	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	564	arnA_1	1983	1717	98.49	arnA_1.l6.c4.ctg.1	1912	14.3	0	.	p	.	0	I150V	NONSYN	448	450	ATT	184	186	GTT	4;4;4	G;T;T	3;3;4	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	564	arnA_1	1983	1717	98.49	arnA_1.l6.c4.ctg.1	1912	14.3	0	.	p	.	0	R200H	NONSYN	598	600	CGC	334	336	CAC	9;11;11	C;A;C	9;11;11	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	564	arnA_1	1983	1717	98.49	arnA_1.l6.c4.ctg.1	1912	14.3	0	.	p	.	0	T295M	NONSYN	883	885	ACG	619	621	ATG	19;19;19	A;T;G	19;19;19	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	564	arnA_1	1983	1717	98.49	arnA_1.l6.c4.ctg.1	1912	14.3	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1615	1617	CGC	17;15;15	C;G;C	17;15;15	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	564	arnA_1	1983	100	97.0	arnA_1.l6.c4.ctg.2	100	9.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	298	bacA	822	822	98.54	bacA.l6.c30.ctg.1	1037	13.8	0	.	p	.	0	S221T	NONSYN	661	663	AGC	728	730	ACC	5;5;5	A;C;C	5;5;5	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	298	bacA	822	822	98.54	bacA.l6.c30.ctg.1	1037	13.8	0	.	p	.	0	P225S	NONSYN	673	675	CCG	740	742	TCG	9;10;10	T;C;G	9;10;10	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	1	230	baeR	723	208	98.08	baeR.l15.c4.ctg.1	361	7.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	1	230	baeR	723	517	97.68	baeR.l15.c4.ctg.2	555	14.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	382	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1609	11.7	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1280	1282	AAA	7;7;7	A;A;A	7;7;7	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	382	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1609	11.7	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1292	1294	GAG	5;6;6	G;A;G	4;6;6	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	382	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1609	11.7	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1298	1300	CAC	8;8;7	C;A;C	8;8;7	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	382	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1609	11.7	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1352	1354	GAG	12;12;12	G,C;A;G	11,1;12;12	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	520	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1774	14.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	318	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1092	14.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	310	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1179	12.6	0	.	p	.	0	A146T	NONSYN	436	438	GCT	634	636	ACT	12;12;12	A;C;T	12;12;12	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	1	0	27	180	dfrA1_1	474	474	100.0	dfrA1_1.l15.c4.ctg.1	753	11.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	376	emrA	1173	1173	98.29	emrA.l15.c17.ctg.2	1293	13.5	0	.	p	.	0	I219V	NONSYN	655	657	ATC	667	669	GTC	10;10;11	G;T;C	10;9;10	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	614	emrB	1539	1539	99.74	emrB.l15.c30.ctg.1	1899	16.2	0	.	p	.	0	E197K	NONSYN	589	591	GAA	770	772	AAA	17;17;17	A;A;A	17;17;17	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	515	410	emrD	1191	1094	98.35	emrD.l15.c4.ctg.1	1288	15.0	0	.	p	.	0	G209S	NONSYN	625	627	GGC	819	821	AGC	16;15;14	A;G;C	16;15;13	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	515	410	emrD	1191	97	98.97	emrD.l15.c4.ctg.2	103	9.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	262	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1240	9.9	0	.	p	.	0	K176R	NONSYN	526	528	AAG	693	695	AGG	9;9;9	A;G;G	9;9;9	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	262	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1240	9.9	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1083	1085	GAC	3;3;3	G;A;C	3;3;3	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	262	emrR	531	531	100.0	emrR.l15.c4.ctg.1	948	14.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	516	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1994	12.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	176	evgA	615	615	99.19	evgA.l15.c4.ctg.1	1025	8.7	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	397	399	CTG	15;14;14	C;T;G	13;14;14	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	1971	98.12	evgS.l6.c30.ctg.1	2195	14.2	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	409	411	CAT	10;11;11	C;A;T	10;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	1971	98.12	evgS.l6.c30.ctg.1	2195	14.2	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	463	465	CAT	6;5;5	C;A;T	6;5;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	1971	98.12	evgS.l6.c30.ctg.1	2195	14.2	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	481	483	AGA	8;9;9	A;G;A	8;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	1971	98.12	evgS.l6.c30.ctg.1	2195	14.2	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	496	498	AAT	13;12;12	A;A;T	13;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	1971	98.12	evgS.l6.c30.ctg.1	2195	14.2	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	643	645	TCC	2;2;2	T;C;C	2;2;2	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	1971	98.12	evgS.l6.c30.ctg.1	2195	14.2	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	808	810	ATT	14;14;13	A;T;T	14;14;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	1971	98.12	evgS.l6.c30.ctg.1	2195	14.2	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	829	831	GAT	5;5;5	G;A;T	5;5;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	1971	98.12	evgS.l6.c30.ctg.1	2195	14.2	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	943	945	GTT	13;14;14	G;T;T	13;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	1971	98.12	evgS.l6.c30.ctg.1	2195	14.2	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1228	1230	CAC	5;5;6	C;A;C	5;5;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	557	97.13	evgS.l6.c30.ctg.2	563	9.6	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	196	198	AAA	8;8;8	A;A;A	8;8;8	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	881	97.39	evgS.l6.c30.ctg.3	930	9.9	0	.	p	.	0	T38I	NONSYN	112	114	ACA	161	163	ATA	6;6;6	A;T;A	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	881	97.39	evgS.l6.c30.ctg.3	930	9.9	0	.	p	.	0	L42V	NONSYN	124	126	CTA	173	175	GTA	3;3;3	G;T;A	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	881	97.39	evgS.l6.c30.ctg.3	930	9.9	0	.	p	.	0	A93T	NONSYN	277	279	GCG	326	328	ACG	14;14;14	A;C;G	14;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	881	97.39	evgS.l6.c30.ctg.3	930	9.9	0	.	p	.	0	A114E	NONSYN	340	342	GCA	389	391	GAA	11;11;11	G;A;A	11;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	881	97.39	evgS.l6.c30.ctg.3	930	9.9	0	.	p	.	0	T127A	NONSYN	379	381	ACT	428	430	GCT	14;14;14	G;C;T	14;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	881	97.39	evgS.l6.c30.ctg.3	930	9.9	0	.	p	.	0	N133D	NONSYN	397	399	AAT	446	448	GAT	10;10;10	G;A;T	10;10;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	881	97.39	evgS.l6.c30.ctg.3	930	9.9	0	.	p	.	0	P162S	NONSYN	484	486	CCA	533	535	TCA	7;7;7	T;C;A	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	881	97.39	evgS.l6.c30.ctg.3	930	9.9	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	662	664	CAG	5;5;5	C;A;G	5;5;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	932	evgS	3594	881	97.39	evgS.l6.c30.ctg.3	930	9.9	0	.	p	.	0	I251V	NONSYN	751	753	ATT	800	802	GTT	8;8;7	G;T;T	8;8;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	276	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1139	11.6	1	SNP	p	P64L	0	.	.	190	192	CCA	297	299	CCA	11;12;11	C;C;A	11;11;11	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	276	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1139	11.6	1	SNP	p	P64S	0	.	.	190	192	CCA	297	299	CCA	11;12;11	C;C;A	11;11;11	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	276	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1139	11.6	1	SNP	p	P64A	0	.	.	190	192	CCA	297	299	CCA	11;12;11	C;C;A	11;11;11	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	276	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1139	11.6	1	SNP	p	P64R	0	.	.	190	192	CCA	297	299	CCA	11;12;11	C;C;A	11;11;11	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	276	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1139	11.6	1	SNP	p	P64H	0	.	.	190	192	CCA	297	299	CCA	11;12;11	C;C;A	11;11;11	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	216	gadE	528	528	100.0	gadE.l15.c30.ctg.1	875	12.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	68	gadW	729	133	96.99	gadW.l15.c4.ctg.1	133	12.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	68	gadW	729	160	93.12	gadW.l15.c4.ctg.2	160	6.4	0	.	p	.	0	D100E	NONSYN	298	300	GAC	4	6	GAA	1;1;1	G;A;A	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	68	gadW	729	160	93.12	gadW.l15.c4.ctg.2	160	6.4	0	.	p	.	0	P101S	NONSYN	301	303	CCC	7	9	TCC	1;1;1	T;C;C	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	68	gadW	729	160	93.12	gadW.l15.c4.ctg.2	160	6.4	0	.	p	.	0	R102G	NONSYN	304	306	CGG	10	12	GGG	1;1;1	G;G;G	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	68	gadW	729	160	93.12	gadW.l15.c4.ctg.2	160	6.4	0	.	p	.	0	K110N	NONSYN	328	330	AAA	34	36	AAT	4;4;4	A;A;T	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	214	gadX	825	825	97.94	gadX.l15.c4.ctg.1	929	10.8	0	.	p	.	0	F53L	NONSYN	157	159	TTC	174	176	TTA	2;2;3	T;T;A	2;2;3	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	214	gadX	825	825	97.94	gadX.l15.c4.ctg.1	929	10.8	0	.	p	.	0	V79I	NONSYN	235	237	GTT	252	254	ATT	12;12;13	A;T;T	12;12;13	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	214	gadX	825	825	97.94	gadX.l15.c4.ctg.1	929	10.8	0	.	p	.	0	R246G	NONSYN	736	738	AGA	753	755	GGA	7;7;7	G;G;A	7;7;7	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	214	gadX	825	825	97.94	gadX.l15.c4.ctg.1	929	10.8	0	.	p	.	0	S248P	NONSYN	742	744	TCG	759	761	CCG	5;5;5	C;C;G	5;5;5	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1006	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3048	16.7	1	SNP	p	D87Y	1	D87Y	NONSYN	259	261	GAC	451	453	TAC	15;15;13	T;A;C	15;14;13	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1006	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3048	16.7	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2224	2226	GAA	19;17;17	G;A;A	19;17;17	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1006	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3048	16.7	1	SNP	p	S83I	0	.	.	247	249	TCG	439	441	TCG	15;15;15	T;C;G	14;15;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1006	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3048	16.7	1	SNP	p	S83L	0	.	.	247	249	TCG	439	441	TCG	15;15;15	T;C;G	14;15;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1006	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3048	16.7	1	SNP	p	S83W	0	.	.	247	249	TCG	439	441	TCG	15;15;15	T;C;G	14;15;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	882	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2606	16.6	1	SNP	p	R136G	0	.	.	406	408	CGC	557	559	CGC	13;13;13	C;G;C	13;13;13	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	882	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2606	16.6	1	SNP	p	R136E	0	.	.	406	408	CGC	557	559	CGC	13;13;13	C;G;C	13;13;13	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	882	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2606	16.6	1	SNP	p	R136I	0	.	.	406	408	CGC	557	559	CGC	13;13;13	C;G;C	13;13;13	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	882	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2606	16.6	1	SNP	p	R136L	0	.	.	406	408	CGC	557	559	CGC	13;13;13	C;G;C	13;13;13	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	882	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2606	16.6	1	SNP	p	R136H	0	.	.	406	408	CGC	557	559	CGC	13;13;13	C;G;C	13;13;13	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	882	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2606	16.6	1	SNP	p	R136S	0	.	.	406	408	CGC	557	559	CGC	13;13;13	C;G;C	13;13;13	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	882	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2606	16.6	1	SNP	p	R136C	0	.	.	406	408	CGC	557	559	CGC	13;13;13	C;G;C	13;13;13	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	194	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	941	10.0	0	.	p	.	0	A72P	NONSYN	214	216	GCG	360	362	CCG	13;13;13	C;C;G	13;13;13	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	194	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	941	10.0	0	.	p	.	0	T123A	NONSYN	367	369	ACC	513	515	GCC	10;10;10	G;C;C	10;10;10	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	336	leuO	945	945	99.26	leuO.l6.c30.ctg.1	1168	14.5	0	.	p	.	0	P9S	NONSYN	25	27	CCA	154	156	TCA	8;8;7	T;C;A	8;7;7	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	132	marA	384	384	99.74	marA.l15.c4.ctg.1	733	9.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	517	58	marR	435	284	97.89	marR.l15.c30.ctg.1	332	5.7	0	.	p	.	0	N89fs	FSHIFT	265	265	A	312	312	A	2	A	2	.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	517	58	marR	435	284	97.89	marR.l15.c30.ctg.1	332	5.7	1	SNP	p	V45E	0	.	.	133	135	GTG	180	182	GTG	13;13;12	G;T;G	13;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	517	58	marR	435	284	97.89	marR.l15.c30.ctg.1	332	5.7	1	SNP	p	I49S	0	.	.	145	147	ATC	192	194	ATC	7;7;7	A;T;C	7;6;7	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	517	58	marR	435	284	97.89	marR.l15.c30.ctg.1	332	5.7	1	SNP	p	A70T	0	.	.	208	210	GCA	255	257	GCA	6;6;6	G;C;A	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	517	58	marR	435	284	97.89	marR.l15.c30.ctg.1	332	5.7	1	SNP	p	R73C	0	.	.	217	219	CGT	264	266	CGT	5;5;5	C;G;T	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	517	58	marR	435	284	97.89	marR.l15.c30.ctg.1	332	5.7	1	SNP	p	R73S	0	.	.	217	219	CGT	264	266	CGT	5;5;5	C;G;T	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	517	58	marR	435	284	97.89	marR.l15.c30.ctg.1	332	5.7	1	SNP	p	R77L	0	.	.	229	231	CGC	276	278	CGC	4;4;4	C;G;C	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	517	58	marR	435	284	97.89	marR.l15.c30.ctg.1	332	5.7	1	SNP	p	R77C	0	.	.	229	231	CGC	276	278	CGC	4;4;4	C;G;C	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	517	58	marR	435	284	97.89	marR.l15.c30.ctg.1	332	5.7	1	SNP	p	L78M	0	.	.	232	234	CTG	279	281	CTG	5;4;4	C;T;G	5;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	517	58	marR	435	148	96.62	marR.l15.c30.ctg.2	148	3.6	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	64	66	AGC	6;5;5	A;G;C	6;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	517	58	marR	435	148	96.62	marR.l15.c30.ctg.2	148	3.6	1	SNP	p	R94H	0	.	.	280	282	CGC	37	39	CGC	4;4;4	C;G;C	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	517	58	marR	435	148	96.62	marR.l15.c30.ctg.2	148	3.6	1	SNP	p	R94S	0	.	.	280	282	CGC	37	39	CGC	4;4;4	C;G;C	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	517	58	marR	435	148	96.62	marR.l15.c30.ctg.2	148	3.6	1	SNP	p	V96E	0	.	.	286	288	GTA	43	45	GTA	4;4;4	G;T;A	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	242	mdfA	1233	835	97.01	mdfA.l6.c4.ctg.1	850	9.2	0	.	p	.	0	R36I	NONSYN	106	108	AGG	89	91	ATC	2;3;4	A;T;C	2;3;4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	242	mdfA	1233	835	97.01	mdfA.l6.c4.ctg.1	850	9.2	0	.	p	.	0	E42A	NONSYN	124	126	GAA	107	109	GCC	2;2;2	G;C;C	2;2;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	242	mdfA	1233	835	97.01	mdfA.l6.c4.ctg.1	850	9.2	0	.	p	.	0	N43V	NONSYN	127	129	AAT	110	112	GTG	2;2;2	G;T;G	2;2;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	242	mdfA	1233	835	97.01	mdfA.l6.c4.ctg.1	850	9.2	0	.	p	.	0	E52D	NONSYN	154	156	GAG	137	139	GAT	3;3;3	G;A;T	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	242	mdfA	1233	835	97.01	mdfA.l6.c4.ctg.1	850	9.2	0	.	p	.	0	N59T	NONSYN	175	177	AAC	158	160	ACC	2;2;2	A;C;C	2;2;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	242	mdfA	1233	835	97.01	mdfA.l6.c4.ctg.1	850	9.2	0	.	p	.	0	I68L	NONSYN	202	204	ATA	185	187	TTA	4;4;4	T;T;A	4;4;4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	242	mdfA	1233	835	97.01	mdfA.l6.c4.ctg.1	850	9.2	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	326	328	CAG	8;8;8	C;A;G	8;8;8	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	242	mdfA	1233	835	97.01	mdfA.l6.c4.ctg.1	850	9.2	0	.	p	.	0	D128A	NONSYN	382	384	GAC	365	367	GCC	3;3;4	G;C;C	3;3;4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	242	mdfA	1233	835	97.01	mdfA.l6.c4.ctg.1	850	9.2	0	.	p	.	0	S163A	NONSYN	487	489	TCG	470	472	GCG	7;7;7	G;C;G	7;7;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	242	mdfA	1233	835	97.01	mdfA.l6.c4.ctg.1	850	9.2	0	.	p	.	0	L231V	NONSYN	691	693	CTT	674	676	GTT	4;6;6	G;T;T	3;6;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	242	mdfA	1233	343	98.54	mdfA.l6.c4.ctg.2	564	7.4	0	.	p	.	0	V343D	NONSYN	1027	1029	GTT	137	139	GAT	5;5;6	G;A;T	5;5;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	242	mdfA	1233	343	98.54	mdfA.l6.c4.ctg.2	564	7.4	0	.	p	.	0	L379Q	NONSYN	1135	1137	CTG	245	247	CAG	7;7;7	C;A;G	7;7;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	242	mdfA	1233	343	98.54	mdfA.l6.c4.ctg.2	564	7.4	0	.	p	.	0	L391W	NONSYN	1171	1173	TTG	281	283	TGG	4;4;4	T;G;G	4;4;4	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	318	mdtA	1248	1248	97.28	mdtA.l15.c4.ctg.1	1548	10.5	0	.	p	.	0	V12trunc	TRUNC	34	34	G	198	198	G	16	G	16	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	318	mdtA	1248	1248	97.28	mdtA.l15.c4.ctg.1	1548	10.5	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	255	257	CAG	5;5;5	C;A;G	5;5;5	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	318	mdtA	1248	1248	97.28	mdtA.l15.c4.ctg.1	1548	10.5	0	.	p	.	0	A48V	NONSYN	142	144	GCG	300	302	GTG	5;5;5	G;T;G	5;5;5	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	318	mdtA	1248	1248	97.28	mdtA.l15.c4.ctg.1	1548	10.5	0	.	p	.	0	T83I	NONSYN	247	249	ACC	405	407	ATC	5;5;5	A;T;C	5;5;5	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	318	mdtA	1248	1248	97.28	mdtA.l15.c4.ctg.1	1548	10.5	0	.	p	.	0	I99M	NONSYN	295	297	ATA	453	455	ATG	3;3;3	A;T;G	3;3;3	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	318	mdtA	1248	1248	97.28	mdtA.l15.c4.ctg.1	1548	10.5	0	.	p	.	0	A130T	NONSYN	388	390	GCC	546	548	ACC	10;10;9	A;C;C	10;10;9	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	318	mdtA	1248	1248	97.28	mdtA.l15.c4.ctg.1	1548	10.5	0	.	p	.	0	P257T	NONSYN	769	771	CCG	927	929	ACG	12;12;13	A;C;G	12;12;13	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1108	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3393	16.5	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1959	1961	ACC	15;16;17	A;C;C	14;15;16	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1108	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3393	16.5	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2352	2354	CAA	14;14;13	C;A;A	14;14;13	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1108	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3393	16.5	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2520	2522	ATT	10;9;9	A;T;T	10;9;9	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1108	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3393	16.5	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2604	2606	GTT	7;7;8	G;T;T	7;7;8	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1108	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3393	16.5	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2712	2714	GAG	5;6;7	G;A;G	5;6;7	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1108	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3393	16.5	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2940	2942	ATG	13;14;13	A;T;G	13;14;13	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1108	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3393	16.5	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3075	3077	GAT	12;13;14	G;A;T	12;13;14	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	1068	mdtC	3078	2934	98.74	mdtC.l15.c4.ctg.1	3063	16.8	0	.	p	.	0	I46M	NONSYN	136	138	ATC	265	267	ATG	11;11;11	A;T;G	11;11;11	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	1068	mdtC	3078	2934	98.74	mdtC.l15.c4.ctg.1	3063	16.8	0	.	p	.	0	V208I	NONSYN	622	624	GTC	751	753	ATC	22;21;21	A;T;C	22;21;21	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	1068	mdtC	3078	136	97.79	mdtC.l15.c4.ctg.3	198	6.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	502	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1698	14.8	0	.	p	.	0	D3E	NONSYN	7	9	GAT	86	88	GAA	5;5;5	G;A;A	5;5;5	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	502	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1698	14.8	0	.	p	.	0	T226A	NONSYN	676	678	ACG	755	757	GCG	24;24;24	G;C;G	24;22;23	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	502	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1698	14.8	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1097	1099	ATC	17;17;19	A;T;C	17;16;19	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	502	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1698	14.8	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1400	1402	TTT	9;10;8	T;T;T	9;10;8	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	510	mdtE	1158	1158	99.31	mdtE.l6.c30.ctg.1	1617	15.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1168	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3552	16.5	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1141	1143	ACC	18;18;18	A;C;C	18;17;18	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1168	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3552	16.5	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2383	2385	GAC	14;14;15	G;A;C	14;14;15	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	360	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.1	1446	10.8	0	.	p	.	0	V200I	NONSYN	598	600	GTC	599	601	ATC	10;9;9	A;T;C	10;9;9	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	360	mdtG	1227	172	99.42	mdtG.l15.c30.ctg.2	244	7.2	0	.	p	.	0	E5G	NONSYN	13	15	GAA	3	5	GGA	2;2;2	G;G;A	2;2;2	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	332	mdtH	1209	1203	98.17	mdtH.l6.c4.ctg.1	1347	11.9	0	.	p	.	0	G134C	NONSYN	400	402	GGT	394	396	TGT	14;14;14	T;G;T	14;14;14	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	332	mdtH	1209	1203	98.17	mdtH.l6.c4.ctg.1	1347	11.9	0	.	p	.	0	S324L	NONSYN	970	972	TCG	964	966	TTG	14;14;16	T;T;G	14;14;16	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	332	mdtH	1209	1203	98.17	mdtH.l6.c4.ctg.1	1347	11.9	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1174	1176	ACG	6;6;7	A;C;G	6;6;7	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	436	mdtL	1176	1176	98.38	mdtL.l15.c17.ctg.1	1338	15.4	0	.	p	.	0	A185S	NONSYN	553	555	GCC	665	667	TCC	6;6;6	T;C;C	6;6;6	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	354	mdtN	1032	1032	98.06	mdtN.l6.c4.ctg.1	1393	12.6	0	.	p	.	0	V119I	NONSYN	355	357	GTT	539	541	ATT	9;9;9	A;T;T	9;9;8	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	788	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2468	16.0	0	.	p	.	0	V11M	NONSYN	31	33	GTG	197	199	ATG	13;14;14	A;T;G	13;13;14	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	788	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2468	16.0	0	.	p	.	0	T33I	NONSYN	97	99	ACC	263	265	ATC	11;11;11	A;T;C	11;11;11	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	788	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2468	16.0	0	.	p	.	0	C116R	NONSYN	346	348	TGC	512	514	CGC	25;25;23	C;G;C	25;25;23	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	788	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2468	16.0	0	.	p	.	0	N238S	NONSYN	712	714	AAC	878	880	AGC	23;22;23	A;G;C	23;22;23	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	788	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2468	16.0	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1079	1081	GTG	23;24;23	G;T;G	23;24;23	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	788	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2468	16.0	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1142	1144	AAC	7;6;6	A;A;C	7;5;6	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	788	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2468	16.0	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1187	1189	GTC	10;11;11	G;T;C	10;10;11	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	788	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2468	16.0	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1217	1219	ATA	17;18;17	A;T;A	17;18;17	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	788	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2468	16.0	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1325	1327	TCT	7;9;9	T;C;T	7;9;9	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	788	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2468	16.0	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1712	1714	GCG	16;16;16	G;C;G	16;16;16	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	788	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2468	16.0	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1925	1927	ATC	19;17;16	A;T;C	19;17;16	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	426	mdtP	1467	1454	97.94	mdtP.l15.c30.ctg.1	1510	13.6	0	.	p	.	0	S129A	NONSYN	385	387	TCA	441	443	GCG	12;11;11	G;C;G	12;11;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	426	mdtP	1467	1454	97.94	mdtP.l15.c30.ctg.1	1510	13.6	0	.	p	.	0	A187T	NONSYN	559	561	GCC	615	617	ACC	19;19;18	A;C;C	19;19;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	426	mdtP	1467	1454	97.94	mdtP.l15.c30.ctg.1	1510	13.6	0	.	p	.	0	H211R	NONSYN	631	633	CAC	687	689	CGC	15;13;13	C;G;C	15;13;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	426	mdtP	1467	1454	97.94	mdtP.l15.c30.ctg.1	1510	13.6	0	.	p	.	0	V250A	NONSYN	748	750	GTT	804	806	GCT	13;13;13	G;C;T	12;13;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	426	mdtP	1467	1454	97.94	mdtP.l15.c30.ctg.1	1510	13.6	0	.	p	.	0	R278K	NONSYN	832	834	AGA	888	890	AAA	9;9;8	A;A;A	9;9;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	426	mdtP	1467	1454	97.94	mdtP.l15.c30.ctg.1	1510	13.6	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	906	908	CGA	11;11;11	C;G;A	11;11;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	426	mdtP	1467	1454	97.94	mdtP.l15.c30.ctg.1	1510	13.6	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1071	1073	GCC	5;5;5	G;C;C	5;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	426	mdtP	1467	1454	97.94	mdtP.l15.c30.ctg.1	1510	13.6	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1083	1085	GAT	8;8;8	G;A;T	8;8;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	426	mdtP	1467	1454	97.94	mdtP.l15.c30.ctg.1	1510	13.6	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1500	1502	GCT	3;3;3	G;C;T	3;3;3	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	996	mfd	3447	3447	99.16	mfd.l15.c17.ctg.1	3695	13.4	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1318	1320	AAG	9;9;9	A;A;G	9;9;9	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	996	mfd	3447	3447	99.16	mfd.l15.c17.ctg.1	3695	13.4	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2395	2397	CTG	16;17;17	C;T;G	16;17;17	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	19	52	mgrB	144	143	100.0	mgrB.l15.c30.ctg.2	192	7.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	546	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	1997	13.8	0	.	p	.	0	S278N	NONSYN	832	834	AGC	875	877	AAC	11;11;11	A;A;C	11;11;11	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	546	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	1997	13.8	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1421	1423	ATA	15;14;14	A;T;A	15;14;14	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	560	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1641	17.2	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1297	1299	GAT	25;25;26	G;A;T	25;25;25	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	560	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1641	17.2	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1300	1302	CTG	23;24;27	C;T;G	23;23;27	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	200	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1171	8.5	0	.	p	.	0	R27C	NONSYN	79	81	CGT	328	330	TGT	10;10;9	T;G;T	10;10;9	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	200	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1171	8.5	0	.	p	.	0	I117T	NONSYN	349	351	ATC	598	600	ACC	10;10;11	A;C;C	10;10;11	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	200	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1171	8.5	0	.	p	.	0	G187D	NONSYN	559	561	GGC	808	810	GAC	13;14;14	G;A;C	13;14;14	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	200	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1171	8.5	1	SNP	p	R15C	0	.	.	43	45	CGC	292	294	CGC	16;17;17	C;G;C	16;17;17	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	200	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1171	8.5	1	SNP	p	S33R	0	.	.	97	99	AGC	346	348	AGC	8;7;6	A;G;C	8;7;6	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	200	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1171	8.5	1	SNP	p	G131D	0	.	.	391	393	GGC	640	642	GGC	14;14;14	G;G;C	14;14;13	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	200	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1171	8.5	1	SNP	p	R203L	0	.	.	607	609	CGT	856	858	CGT	13;13;13	C;G;T	13;13;13	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	200	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1171	8.5	1	SNP	p	R203C	0	.	.	607	609	CGT	856	858	CGT	13;13;13	C;G;T	13;13;13	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	336	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1297	12.3	0	.	p	.	0	D312E	NONSYN	934	936	GAT	947	949	GAG	13;13;13	G;A;G	13;13;13	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	336	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1297	12.3	1	SNP	p	G141E	0	.	.	421	423	GGT	434	436	GGT	25;25;25	G;G;T	25;25;25	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	336	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1297	12.3	1	SNP	p	G141D	0	.	.	421	423	GGT	434	436	GGT	25;25;25	G;G;T	25;25;25	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	336	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1297	12.3	1	SNP	p	R154A	0	.	.	460	462	CGT	473	475	CGT	14;14;13	C;G;T	14;14;13	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	336	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1297	12.3	1	SNP	p	R154D	0	.	.	460	462	CGT	473	475	CGT	14;14;13	C;G;T	14;14;13	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	996	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2657	18.6	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1811	1813	GTG	14;14;14	G;T;G	14;14;14	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	996	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2657	18.6	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1838	1840	TCG	13;13;12	T;C;G	11;11;11	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	996	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2657	18.6	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2453	2455	AAC	14;14;14	A;A;C	14;14;14	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	996	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2657	18.6	1	SNP	p	A85T	0	.	.	253	255	GCG	467	469	GCG	25;25;25	G;C;G	25;25;24	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	996	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2657	18.6	1	SNP	p	D111H	0	.	.	331	333	GAT	545	547	GAT	22;22;22	G;A,T;T	22;21,1;21	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	996	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2657	18.6	1	SNP	p	S129P	0	.	.	385	387	TCC	599	601	TCC	16;16;17	T;C;C	16;16;16	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	517	600	parE_1	1893	985	96.65	parE_1.l6.c4.ctg.1	985	13.0	0	.	p	.	0	S374F	NONSYN	1120	1122	TCC	981	983	TTC	2;2;2	T;T,C;C	2;0,2;2	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	517	600	parE_1	1893	806	97.89	parE_1.l6.c4.ctg.2	1073	12.8	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	330	332	AAC	11;11;11	A;A;C	11;11;11	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	517	600	parE_1	1893	806	97.89	parE_1.l6.c4.ctg.2	1073	12.8	1	SNP	p	D476N	0	.	.	1426	1428	GAT	339	341	GAT	14;17;18	G;A;T	14;17;18	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	517	600	parE_1	1893	163	98.16	parE_1.l6.c4.ctg.4	180	14.8	0	.	p	.	0	R54S	NONSYN	160	162	CGC	177	179	AGC	1;1;1	A;G;C	0;0;0	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	622	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1818	17.1	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	807	809	CAG	10;10;10	C;A;G	10;10;10	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	622	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1818	17.1	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1281	1283	GAT	14;13;13	G;A;T	14;13;13	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1610	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4388	18.5	1	SNP	p	V146F	0	.	.	436	438	GTT	610	612	GTT	18;18;19	G;T;T	18;18;19	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1610	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4388	18.5	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1711	1713	CAG	19;19;20	C;A;G	19;19;19	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1610	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4388	18.5	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1711	1713	CAG	19;19;20	C;A;G	19;19;19	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1610	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4388	18.5	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1750	1752	CAC	23;23;22	C;A;C	23;23;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1610	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4388	18.5	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1759	1761	CGT	20;20;18	C;G;T	20;20;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1610	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4388	18.5	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1759	1761	CGT	20;20;18	C;G;T	20;20;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1610	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4388	18.5	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1765	1767	TCC	16;16;15	T;C;C	16;16;15	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1610	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4388	18.5	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1771	1773	CTC	17;16;15	C;T;C	17;16;15	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1610	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4388	18.5	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1861	1863	ACC	28;28;27	A;C;C	28;28;27	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1610	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4388	18.5	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1864	1866	CCT	25;27;26	C;C;T	25;27;26	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1610	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4388	18.5	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2233	2235	CGT	21;19;17	C;G;T	21;19;17	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.3	517	126.1	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	76	A,G	74,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.3	517	126.1	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	76	A,G	74,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.3	517	126.1	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	76	A,G	74,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.4	1145	105.8	0	.	n	.	0	A226G	SNP	226	226	A	370	370	G	131	G	130	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.4	1145	105.8	0	.	n	.	0	C719T	SNP	719	719	C	863	863	T	103	T,C	50,53	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.4	1145	105.8	1	SNP	n	A794T	0	.	.	794	794	A	938	938	A	116	A	116	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.4	1145	105.8	1	SNP	n	A794G	0	.	.	794	794	A	938	938	A	116	A	116	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.4	1145	105.8	1	SNP	n	G926C	0	.	.	926	926	G	1070	1070	G	111	G	111	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.4	1145	105.8	1	SNP	n	G926T	0	.	.	926	926	G	1070	1070	G	111	G	111	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.4	1145	105.8	1	SNP	n	G926A	0	.	.	926	926	G	1070	1070	G	111	G	111	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.4	1145	105.8	0	HET	.	.	.	T273A	.	273	273	T	417	417	T	98	T,A	72,23	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.4	1145	105.8	0	HET	.	.	.	C183T	.	183	183	C	327	327	C	115	C,T	72,40	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.4	1145	105.8	0	HET	.	.	.	T90C	.	90	90	T	234	234	T	112	T,C	84,27	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.4	1145	105.8	0	HET	.	.	.	A250T	.	250	250	A	394	394	A	119	A,T	90,29	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.4	1145	105.8	0	HET	.	.	.	G474A	.	474	474	G	618	618	G	106	G,A	86,19	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.4	1145	105.8	0	HET	.	.	.	A253T	.	253	253	A	397	397	A	117	A,T	86,28	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.4	1145	105.8	0	HET	.	.	.	C194T	.	194	194	C	338	338	C	116	C,T	85,29	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.4	1145	105.8	0	HET	.	.	.	A79G	.	79	79	A	223	223	A	116	A,G	90,26	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	143	100.0	rrsB+.l15.c30.ctg.5	143	29.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.6	139	20.4	0	.	n	.	0	G1002A	SNP	1002	1002	G	53	53	A	34	A	34	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.6	139	20.4	0	.	n	.	0	G1006C	SNP	1006	1006	G	57	57	C	37	C	37	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.6	139	20.4	0	.	n	.	0	T1010C	SNP	1010	1010	T	61	61	C	37	C	37	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.6	139	20.4	0	.	n	.	0	A1019.	DEL	1019	1019	A	69	69	G	41	G	41	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.6	139	20.4	0	.	n	.	0	.1023G	INS	1023	1023	T	74	74	G	39	G	38	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4120	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.6	139	20.4	0	.	n	.	0	C1038T	SNP	1038	1038	C	89	89	T	35	T	35	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	218	sat_1	525	525	100.0	sat_1.l6.c4.ctg.1	893	12.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	196	soxR	465	465	100.0	soxR.l6.c4.ctg.1	805	12.3	1	SNP	p	R20H	0	.	.	58	60	CGC	231	233	CGC	20;19;18	C;G;C	20;19;18	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	196	soxR	465	465	100.0	soxR.l6.c4.ctg.1	805	12.3	1	SNP	p	G121D	0	.	.	361	363	GGT	534	536	GGT	14;15;15	G;G;T	14;15;15	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	130	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	507	10.6	1	SNP	p	A12S	0	.	.	34	36	GCA	149	151	GCA	21;21;21	G;C;A	21;21;21	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	5438	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l15.c17.ctg.1	1258	225.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	5682	APH_6__Id+	837	837	100.0	APH_6__Id+.l15.c17.ctg.1	1288	230.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.3000412.AY055428.20268_21084.552	sul2.3000412.AY055428.20268_21084.552	1	0	27	4334	sul2	816	816	100.0	sul2.l15.c4.ctg.1	1314	172.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sul2;Sul2 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria, usually found on small plasmids.
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	6676	tetA	1200	1200	100.0	tetA.l15.c4.ctg.1	1673	207.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	4054	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1090	193.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	540	tolC	1488	1488	98.72	tolC.l6.c30.ctg.1	1914	14.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
